Together, these results demonstrated that high TW expression is associated with increased GBM malignancy and POSTN expression supporting the broader potential clinical relevance of TW‐mediated regulation of POSTN for malignancy and that targeting this signaling axis may be most productive in specific GBM subtypes. Here, POSTN is linked to glioblastoma.